Monthly fee: none Lock-in: none, no commitment required Cancellation: online portal, no phone call Price at every dose: flat $199 Refund: prorated if provider confirms a medical stop
Adding glucagon agonism to GLP-1/GIP would seem counterproductive glucagon normally raises blood glucose, which works against the insulin-promoting effects
The GIP and glucagon receptor effects take longer to manifest at measurable levels
The metabolic rate increase from retatrutide's glucagon component is active as long as you're taking the medication
Nearly two-thirds lost 20% or more
General inflammatory markers: High-sensitivity CRP (hs-CRP), the most responsive general marker Erythrocyte sedimentation rate (ESR) Fibrinogen Condition-specific markers: Rheumatoid arthritis: RF, anti-CCP, DAS28 score Hashimoto thyroiditis: TPO antibodies, thyroglobulin antibodies, TSH Psoriasis: PASI score, BSA involvement IBD: Fecal calprotectin, SES-CD or Mayo score Lupus: ANA, anti-dsDNA, complement C3/C4 Cytokine panels (when available): TNF-alpha IL-6 IL-1 beta IL-17 (particularly relevant for psoriasis and spondyloarthritis) The recommendation from most practitioners is baseline testing before starting, a 4 to 6 week interim check, and a full reassessment at 12 weeks
